Identification and characterization of ErbB-3-binding protein-1 as a target for immunotherapy

Journal of Immunology

Volumn 179, Issue 3, 2007, Pages 2005-2012

  Santegoets, Saskia J A M ^a   Schreurs, Marco W J ^a   Reurs, Anneke W ^a   Lindenberg, Jelle J ^a   Kueter, Esther W M ^a   Van Den Eertwegh, Alfons J M ^a   Hooijberg, Erik ^a   Brandwijk, Ricardo J ^b   Hufton, Simon E ^b,c   Hoogenboom, Hennie R ^b,c   Scheper, Rik J ^a,d   Somers, Veerle A ^b,e   De Gruijl, Tanja D ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c Building 22   (Belgium)

^d De Boelelaan 1105   (Netherlands)

^e HASSELT UNIVERSITY   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; COMPLEMENTARY DNA; EPIDERMAL GROWTH FACTOR RECEPTOR 3; HLA A2 ANTIGEN; IMMUNOGLOBULIN G; EPITOPE; PA2G4 PROTEIN, HUMAN; RNA BINDING PROTEIN; SIGNAL TRANSDUCING ADAPTOR PROTEIN; TUMOR ANTIGEN; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; COLORECTAL TUMOR; CONTROLLED STUDY; GENE IDENTIFICATION; HUMAN; HUMAN CELL; IMMUNOGENICITY; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; IMMUNOREACTIVITY; IMMUNOTHERAPY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SCREENING; SEQUENCE ANALYSIS; SEROLOGY; STAINING; T LYMPHOCYTE; BIOSYNTHESIS; BREAST TUMOR; CELL LINE; CELL STRAIN HT29; CHEMISTRY; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY TEST; DRUG DELIVERY SYSTEM; GENE LIBRARY; GENETICS; METABOLISM; METHODOLOGY; MOLECULAR CLONING; PASSIVE IMMUNIZATION; PATHOLOGY; TUMOR CELL LINE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANTIGENS, NEOPLASM; BREAST NEOPLASMS; CELL LINE; CELL LINE, TUMOR; CLONING, MOLECULAR; COLORECTAL NEOPLASMS; CYTOTOXICITY TESTS, IMMUNOLOGIC; DNA, COMPLEMENTARY; DRUG DELIVERY SYSTEMS; EPITOPES, T-LYMPHOCYTE; GENE LIBRARY; HLA-A2 ANTIGEN; HT29 CELLS; HUMANS; IMMUNIZATION, PASSIVE; RECEPTOR, ERBB-3; RNA-BINDING PROTEINS; T-LYMPHOCYTES, CYTOTOXIC;

EID: 34548656993     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.179.3.2005     Document Type: Article

References (37)

1. Kawakami, Y., S. Eliyahu, C. H. Delgado, P. F. Robbins, L. Rivoltini, S. L. Topalian, T. Miki, and S. A. Rosenberg. 1994. Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor. Proc. Natl. Acad. Sci. USA 91: 3515-3519.
2. van der, B. P., C. Traversari, P. Chomez, C. Lurquin, E. De Plaen, E. B. Van den, A. Knuth, and T. Boon. 1991. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science 254: 1643-1647.
3. Coulie, P. G., V. Brichard, A. Van Pel, T. Wolfel, J. Schneider, C. Traversari, S. Mattei, E. De Plaen, C. Lurquin, J. P. Szikora, et al. 1994. A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J. Exp. Med. 180: 35-42.
4. Brichard, V., A. Van Pel, T. Wolfel, C. Wolfel, E. De Plaen, B. Lethe, P. Coulie, and T. Boon. 1993. The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J. Exp. Med. 178: 489-495.
5. Sahin, U., O. Tureci, H. Schmitt, B. Cochlovius, T. Johannes, R. Schmits, F. Stenner, G. Luo, I. Schobert, and M. Pfreundschuh. 1995. Human neoplasms elicit multiple specific immune responses in the autologous host. Proc. Natl. Acad. Sci. USA 92: 11810-11813.
6. Tureci, O., U. Sahin, I. Schobert, M. Koslowski, H. Scmitt, H. J. Schild, F. Stenner, G. Seitz, H. G. Rammensee, and M. Pfreundschuh. 1996. The SSX-2 gene, which is involved in the t(X;18) translocation of synovial sarcomas, codes for the human tumor antigen HOM-MEL-40. Cancer Res. 56: 4766-4772.
7. Chen, Y. T., M. J. Scanlan, U. Sahin, O. Tureci, A. O. Gure, S. Tsang, B. Williamson, E. Stockert, M. Pfreundschuh, and L. J. Old. 1997. A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening. Proc. Natl. Acad. Sci. USA 94: 1914-1918.
8. Vermorken, J. B., A. M. Claessen, H. van Tinteren, H. E. Gall, R. Ezinga, S. Meijer, R. J. Scheper, C. J. Meijer, E. Bloemena, J. H. Ransom, et al. 1999. Active specific immunotherapy for stage II and stage III human colon cancer: a randomised trial. Lancet 353: 345-350.
9. Hufton, S. E., P. T. Moerkerk, E. V. Meulemans, A. de Bruine, J. W. Arends, and H. R. Hoogenboom. 1999. Phage display of cDNA repertoires: the pVI display system and its applications for the selection of immunogenic ligands. J. Immunol. Methods 231: 39-51.
10. Somers, V. A., R. J. Brandwijk, B. Joosten, P. T. Moerkerk, J. W. Arends, P. Menheere, W. O. Pieterse, A. Claessen, R. J. Scheper, H. R. Hoogenboom, and S. E. Hufton. 2002. A panel of candidate tumor antigens in colorectal cancer revealed by the serological selection of a phage displayed cDNA expression library. J. Immunol. 169: 2772-2780.
11. Rammensee, H., J. Bachmann, N. P. Emmerich, O. A. Bachor, and S. Stevanovic. 1999. SYFPEITHI: database for MHC ligands and peptide motifs. Immunogenetics 50: 213-219.
12. Nijman, H. W., J. G. Houbiers, M. P. Vierboom, S. H. van der Burg, J. W. Drijfhout, J. D'Amaro, P. Kenemans, C. J. Melief, and W. M. Kast. 1993. Identification of peptide sequences that potentially trigger HLA-A2.1-restricted cytotoxic T lymphocytes. Eur. J. Immunol. 23: 1215-1219.
13. Kessler, J. H., B. Mommaas, T. Mutis, I. Huijbers, D. Vissers, W. E. Benckhuijsen, G. M. Schreuder, R. Offringa, E. Goulmy, C. J. Melief, et al. 2003. Competition-based cellular peptide binding assays for 13 prevalent HLA class I alleles using fluorescein-labeled synthetic peptides. Hum. Immunol. 64: 245-255.
14. van der Burg, S. H., E. Ras, J. W. Drijfhout, W. E. Benckhuijsen, A. J. Bremers, C. J. Melief, and W. M. Kast. 1995. An HLA class I peptide-binding assay based on competition for binding to class I molecules on intact human B cells: identification of conserved HIV-1 polymerase peptides binding to HLA-A*0301. Hum. Immunol. 44: 189-198.
15. Heemskerk, M. H., E. Hooijberg, J. J. Ruizendaal, M. M. van der Weide, E. Kueter, A. Q. Bakker, T. N. Schumacher, and H. Spits. 1999. Enrichment of an antigen-specific T cell response by retrovirally transduced human dendritic cells. Cell. Immunol. 195: 10-17.
16. + precursors. Blood 100: 701-703.
17. Bender, A., M. Sapp, G. Schuler, R. M. Steinman, and N. Bhardwaj. 1996. Improved methods for the generation of dendritic cells from nonproliferating progenitors in human blood. J. Immunol. Methods 196: 121-135.
18. Schreurs, M. W., K. B. Scholten, E. W. Kueter, J. J. Ruizendaal, C. J. Meijer, and E. Hooijberg. 2003. In vitro generation and life span extension of human papillomavirus type 16-specific, healthy donor-derived CTL clones. J. Immunol. 171: 2912-2921.
19. Santegoets, S. J., M. W. Schreurs, A. J. Masterson, Y. P. Liu, S. Goletz, H. Baumeister, E. W. Kueter, S. M. Lougheed, A. J. van den Eertwegh, R. J. Scheper, et al. 2006. In vitro priming of tumor-specific cytotoxic T lymphocytes using allogeneic dendritic cells derived from the human MUTZ-3 cell line. Cancer Immunol. Immunother. 55: 1480-1490.
20. + T cells by a flow cytometric assay for degranulation. J. Immunol. Methods 281: 65-78.
21. Rubio, V., T. B. Stuge, N. Singh, M. R. Betts, J. S. Weber, M. Roederer, and P. P. Lee. 2003. Ex vivo identification, isolation and analysis of tumor-cytolytic T cells. Nat. Med. 9: 1377-1382.
22. + progenitor-derived dendritic cell vaccine. Cancer Res. 61: 6451-6458.
23. + memory T cells. J. Exp. Med. 186: 859-865.
24. Vuylsteke, R. J., P. A. van Leeuwen, S. Meijer, P. G. Wijnands, M. G. Statius Muller, D. H. Busch, R. J. Scheper, and T. D. de Gruijl. 2002. Sampling tumor-draining lymph nodes for phenotypic and functional analysis of dendritic cells and T cells. Am. J. Pathol. 161: 19-26.
25. Xia, X., A. Cheng, T. Lessor, Y. Zhang, and A. W. Hamburger. 2001. Ebp1, an ErbB-3 binding protein, interacts with Rb and affects Rb transcriptional regulation. J. Cell. Physiol. 187: 209-217.
26. Yoo, J. Y., X. W. Wang, A. K. Rishi, T. Lessor, X. M. Xia, T. A. Gustafson, and A. W. Hamburger. 2000. Interaction of the PA2G4 (EBP1) protein with ErbB-3 and regulation of this binding by heregulin. Br. J. Cancer 82: 683-690.
27. Lessor, T. J., J. Y. Yoo, X. Xia, N. Woodford, and A. W. Hamburger. 2000. Ectopic expression of the ErbB-3 binding protein ebp1 inhibits growth and induces differentiation of human breast cancer cell lines. J. Cell. Physiol. 183: 321-329.
28. Zhang, Y., N. Woodford, X. Xia, and A. W. Hamburger. 2003. Repression of E2F1-mediated transcription by the ErbB3 binding protein Ebp1 involves histone deacetylases. Nucleic Acids Res. 31: 2168-2177.
29. Zhang, Y., J. D. Fondell, Q. Wang, X. Xia, A. Cheng, M. L. Lu, and A. W. Hamburger. 2002. Repression of androgen receptor mediated transcription by the ErbB-3 binding protein, Ebp1. Oncogene 21: 5609-5618.
30. Squatrito, M., M. Mancino, M. Donzelli, L. B. Areces, and G. F. Draetta. 2004. EBP1 is a nucleolar growth-regulating protein that is part of pre-ribosomal ribonucleoprotein complexes. Oncogene 23: 4454-4465.
31. Xia, X., T. J. Lessor, Y. Zhang, N. Woodford, and A. W. Hamburger. 2001. Analysis of the expression pattern of Ebp1, an ErbB-3-binding protein. Biochem. Biophys. Res. Commun. 289: 240-244.
32. + T lymphocytes. Proc. Natl. Acad. Sci. USA 96: 2982-2987.
33. Ludewig, B., A. F. Ochsenbein, B. Odermatt, D. Paulin, H. Hengartner, and R. M. Zinkernagel. 2000. Immunotherapy with dendritic cells directed against tumor antigens shared with normal host cells results in severe autoimmune disease. J. Exp. Med. 191: 795-804.
34. Babatz, J., C. Rollig, B. Lobel, G. Folprecht, M. Haack, H. Gunther, C. H. Kohne, G. Ehninger, M. Schmitz, and M. Bornhauser. 2006. Induction of cellular immune responses against carcinoembryonic antigen in patients with metastatic tumors after vaccination with altered peptide ligand-loaded dendritic cells. Cancer Immunol. Immunother. 55: 268-276.
35. Lesterhuis, W. J., I. J. De Vries, D. H. Schuurhuis, A. C. Boullart, J. F. Jacobs, A. J. de Boer, N. M. Scharenborg, H. M. Brouwer, M. W. van de Rakt, C. G. Figdor, et al. 2006. Vaccination of colorectal cancer patients with CEA-loaded dendritic cells: antigen-specific T cell responses in DTH skin tests. Ann. Oncol. 17: 974-980.
36. Svane, I. M., A. E. Pedersen, H. E. Johnsen, D. Nielsen, C. Kamby, E. Gaarsdal, K. Nikolajsen, S. Buus, and M. H. Claesson. 2004. Vaccination with p53-peptide-pulsed dendritic cells, of patients with advanced breast cancer: report from a phase I study. Cancer Immunol. Immunother. 53: 633-641.
37. Radomski, N., and E. Jost. 1995. Molecular cloning of a murine cDNA encoding a novel protein, p38-2G4, which varies with the cell cycle. Exp. Cell Res. 220: 434-445.